Get assistance from Cosmetic Compliance experts and become ready to sell! Quality Smart Solutions helps cosmetic companies adhere to Food and Drugs Act in Canada and Food and Drug Administration in USA.
Any beauty product that is professionally made for use in cleansing, improving the complexion, skin, hair, or teeth falls under purview of cosmetic regulations. Common cosmetics are fragrance, skincare, hair, and manicure products. Compliance adherence from initial cosmetic product development stage to market execution is necessary as it ensures your products will be approved by the regulatory authorities.
In Canada, the cosmetic market value is anticipated to reach around 15.8 billion U.S. dollars in 2021, which is an increase of almost three billion U.S. dollars from the last five years. When it comes to USA, the revenue generated by the Cosmetic Industry is 49.2 billion US dollars. It is the most valuable beauty and personal care market in the world.
Proven Expertise. Companies who have Trusted Us to Meet Canada and USA Cosmetic Products Regulations
Health Canada and FDA require all cosmetic products sold in Canada and USA to be manufactured, packaged, and stored under hygienic conditions. Regulatory authorities are always monitoring misbranded or adulterated commodities, or inappropriate product packaging. Manufacturers or importers are required to carry a safety assessment before marketing their cosmetic products. According to Health Canada, businesses must notify the regulatory authorities that they are selling cosmetics and must provide a list of the product’s ingredients.
Products must adhere to cosmetic labelling regulations i.e. Food and Drugs Act and Cosmetic Regulations in Canada and FD&C Act and FP&L Act in USA.
Regulatory authorities inspect locations where cosmetics are manufactured or stored, and any advertising or labelling material related to a product.
Product safety assessment is encoded in legal or regulatory responsibilities. Manufacturers, importers, distributors or others must conduct a Safety Assessment of their products to ensure only safe products reach consumers.
Health Canada and FDA can issue a warning letter and take legal action against a cosmetic product on the market if they find information showing that the product is adulterated or misbranded.
Information that must appear on the label of a pre-packaged cosmetic include product identification in English (and French in Canada), product's net quantity declaration in metric units, and identity and location of business of the dealer.
Quality Smart Solutions is committed to helping cosmetic companies comply with cosmetic regulations Canada and USA. We will assist you in cosmetics registration, claim substantiation, notification, French translation, product packaging, and cosmetic labelling regulations.
Cosmetic Notification :
Our Canada Cosmetic Regulatory experts review cosmetic ingredients, then ensure the product does not contain any ingredients on the ‘Ingredient Hotlist’ (substances that may be prohibited or restricted in cosmetics). Once the review is done, we will assist you in preparing and submitting your cosmetic notification application to Health Canada.
Our USA Cosmetic Compliance Solutions comprise two tiers of services. In the first tier, the team will help you by reviewing your artwork and giving suggestions. In the second tier, we design a conversion solution whereby our graphic designer will help you prepare a fully compliant, print-ready art file. However, you need to provide us with the images, logo, and text.
Who needs a Foreign Site Reference Number (FSRN)? For Natural Health Products (NHPs) manufactured, packaged, and/or labeled by sites located outside of Canada, Canadian importers
... Read more
As a license holder for Natural Health Products (NHPs), it is your responsibility to be aware of and educated on all requirements for Canada. This
... Read more
This blog unpacks the distinctions between NHPs, Health Canada & FDA-approved drugs, and cosmetic product regulations that define these products. This will include product classification,
... Read more
Background On April 22, 2022, Health Canada issued a notice to the industry on the interim implementation of electronic labelling for human prescription drugs. Consultation
... Read morePlease complete the form below. We will respond to you soon.
